Currently, there are 3.76B common shares owned by the public and among those 3.13B shares have been available to trade.
The company’s stock has a 5-day price change of -13.07% and -29.34% over the past three months. NU shares are trading 24.61% year to date (YTD), with the 12-month market performance up to 28.15% higher. It has a 12-month low price of $8.06 and touched a high of $16.15 over the same period. NU has an average intraday trading volume of 35.62 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -14.30%, -23.96%, and -18.93% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Nu Holdings Ltd (NYSE: NU) shares accounts for 55.67% of the company’s 3.76B shares outstanding.
It has a market capitalization of $49.54B and a beta (3y monthly) value of 1.05. The stock’s trailing 12-month PE ratio is 28.47, while the earnings-per-share (ttm) stands at $0.36. The company has a debt-to-equity ratio at 0.26. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.93% over the week and 4.23% over the month.
Earnings per share for the fiscal year are expected to increase by 76.45%, and 38.93% over the next financial year.
Looking at the support for the NU, a number of firms have released research notes about the stock. Citigroup stated their Sell rating for the stock in a research note on December 02, 2024, with the firm’s price target at $14.60-$11. UBS was of a view on August 02, 2024 that the stock is Neutral, while JP Morgan gave the stock Neutral rating on July 22, 2024, issuing a price target of $12- $14.50. Barclays on their part issued Overweight rating on June 26, 2024.
